RT-4 cells were washed two times with the same TBS-Ca-Mn buffer before they were incubated with 100 µl of the bacteria suspension (OD600 = 0.001) for 1 h, 37 °C on a plate rocker. Again, the cells were washed two times with the TBS-Ca-Mn buffer to get rid of the unbound bacteria. Subsequently, 100 µl of prepared functionalised CDV loaded with adamantane-mannose ligands were applied to detach bound bacteria from cell surfaces during a 15 min incubation at 37 °C. For quantification, the supernatant was collected and dilutions spread on selective LB-agar plates. After an overnight incubation (37 °C), the grown colonies were counted. 
Compound 1 -Ad-TEG-OH
To a solution of 1-bromoadamantane (6.543 g, 30.4 mmol, 1 eq.) in tetraethylene glycol (150 mL) under argon atmosphere, triethylamine (3 eq., 90 mmol, V = 12.7 mL) was added. After stirring at 180 °C overnight, the mixture was extracted with DCM (200 mL) and water (200 mL). The organic phase was further washed with water (1 x 250 mL) and brine (1 x 250 mL) and dried over MgSO4. After removal of solvent under reduced pressure, the title product was obtained as brown oil (9.474 g, 95%). 
Compound 2
To a stirring solution of 1 (1.66 g, 5.06 mmol, 1 eq.) in DCM (70 mL) at 0 °C, triethylamine (1.5 eq., 7.6 mmol, 1.06 mL) was added. Then, a solution of 4-toluenesulfonyl chloride (1.1 eq., 5.57 mmol, 1.06 g) and catalytic amount of DMAP (62 mg) in DCM (50 mL) was added to above solution. The solution was stirred overnight at room temperature. The solution was quenched by 10% of HCl solution, then washed and extracted with NaHCO3 (1 x 100 mL) solution and brine (1 x 100 mL) The organic phase was combined and dried over MgSO4. After removal of solvent under reduced pressure, the mixture was further purified by column chromatography (ethyl acetate, Rf = 0.75). The title product was obtained as colourless oil (1.74 g, 71%). 
Compound 3
To a solution of D-(+)-mannose (5.4 g, 30 mmol, 1 eq.) in acetate anhydride (6 eq., 180 mmol, V = 17 mL) at 0 °C, 1,4-diazabicyclo[2.2.2]octane (1 eq., 30 mmol, 3.36 g) was added portion by portion over 1 hour. Then, the mixture was warmed up to room temperature and stirred for additional 18 h. The reaction mixture was poured into ice-water mixture (300 mL) and extracted with DCM (2 x 150 mL). The organic phase was further washed with NaHCO3 (3 x 100 mL) and brine (1 x 100 mL) and dried over MgSO4. After removal of solvent under reduced pressure, the title product was obtained as colourless sticky oil (10.997 g, 94%). 
Compound 4
To a solution of 3 (2.278 g, 5.8 mmol, 1 eq.) in dry DCM (20 mL) at room temperature, dimethylaminopropylamine (5 eq., 29.2 mmol, V = 3.6 mL) was added and stirred at this temperature for 3 h. Then trichloroacetonitrile (10 eq., 58 mmol, V = 5.8 mL) and 1,8-diazabicyclo[5. 4 .0]undec-7-ene (0.8 eq., 4.64 mmol, V = 0.69 mL) was added dropwise at 0 °C and stirred for 30 min and additional 2 h at room temperature. The reaction mixture was then diluted with DCM (100 mL) and extracted and washed with 10% HCl (1 x 100 mL), saturated Na2CO3 (1 x 100 mL) and brine (1 x 100 mL). The organic phase was combined and dried over MgSO4. After removal of solvent under reduced pressure, the residue was further purified by column chromatography (pentane : ethyl acetate = 1 : 1, Rf = 0.2). The title product was obtained as yellow oil (609 mg, 21%).
Molecular formula: C16H20NO10Cl3
Compound 5
To a solution of 1 (300 mg, 0.92 mmol, 1.5 eq.) in dry DCM (5 mL), compound 4 (300 mg, 0.61 mmol, 1 eq.) was added and stirred at -5 °C until fully dissolved. Boron trifluoride diethyl etherate (1.5 eq., 0.918 mmol, V = 0.11 mL) was added dropwise and this temperature for 2 h. After additional 2 h stirring at 0 °C, the reaction was quenched by saturated NaHCO3 solution (100 mL) and extracted with DCM (100 mL). The organic phase was washed with 10% HCl (1 x 100 mL), water (1 x 100 mL) and brine (1 x 100 mL) and dried over MgSO4. After removal of solvent under reduced pressure, the residue was further purified by column chromatography (ethyl acetate : pentane = 1 : 1, Rf = 0.18). The title product was obtained as colourless oil (165 mg, 37%). 
Compound 6 -Ad1Man1
To a solution of 5 (165 mg, 0.25 mmol, 1 eq.) in dry methanol (5 mL), sodium methoxide (1.5 eq., 0.375 mmol, 20 mg) was added. After stirring for 6 h at room temperature, the mixture was diluted with methanol (p.a.) and neutralised by Dowex ion exchange resin. The title product was obtained after filtration and concentration under reduced pressure as colourless oil (85 mg, 69%). 
Compound 7
To a solution of 2 (1.156 g, 2.4 mmol, 2.4 eq.) in dry acetonitrile (10 mL) under argon atmosphere, methyl 3,5-dihydroxybenzoate (1 eq., 1.0 mmol, 168 mg) and K2CO3 (10 eq., 10 mmol, 1.38 g) were added. The reaction mixture was then stirred at refluxing temperature for 48 h. The solvent was removed and the residue was re-dissolved in DCM before extracted with water and washed with brine. The organic phase was combined and dried over MgSO4. After removal of the solvent under reduced pressure, the mixture was further purified by column chromatography (DCM : MeOH = 98 : 2, Rf = 0.3).
The title product was obtained as colourless oil (773 mg, 98%). 
Compound 8
To a solution of 7 (1.6 g, 2 mmol, 1 eq.) in methanol, an aqueous solution of lithium hydroxide (4.5 eq., 9 mmol, 213 mg) was added dropwise. The mixture was then stirred at room temperature overnight before being quenched by 10% HCl (2 x 100 mL). The mixture was extracted with DCM (100 mL) and washed with water (1 x 100 mL) and brine (1 x 100 mL). The organic phase was combined and dried over MgSO4. After removal of solvent under reduced pressure, the title product was obtained as colourless oil (1.517 g, 98%). 
Compound 9
To a solution of 8 (0.5 g, 0.65 mmol, 1 eq.) in dry DMF under argon atmosphere, EDC hydrochloride (1.5 eq., 0.975 mmol, 187 mg) and 1-hydroxybenzotriazole hydrate (1.5 eq., 0.975 mmol, 132 mg) were added. After stirring for 30 min, N-methylmorpholine (1.5 eq., 0.975 mmol, V = 1.1 mL) and propargylamine (1.5 eq., 0.975 mmol, V = 0.06 mL) were added and stirred at room temperature overnight. The reaction mixture was quenched by saturated NaHCO3 solution (100 mL) and extracted with DCM (100 mL). The organic phase was further washed with 10% HCl (1 x 100 mL), water (1 x 100 mL), and brine (1 x 100 mL) and dried over MgSO4. After removal of solvent under reduced pressure, the residue was further purified by column chromatography (ethyl acetate, Rf = 0.25). The title product was obtained as colourless oil (350 mg, 62%). 
Compound 10
To a solution of 3 (840 mg, 2.16 mmol, 1 eq.) in dry DCM under argon atmosphere, trimethylsilyl azide (2.5 eq., 5.4 mmol, V = 0.71 mL) was added dropwise. After stirring for 30 min, SnCl4 (0.3 eq., 0.65 mmol, V = 0.1 mL) was added dropwise and stirred at room temperature overnight. The mixture was diluted with DCM (100 mL) and stirred vigorously with saturated NaHCO3 (100 mL) for 30 min. The organic phase was then extracted with water (1 x 100 mL) and brine (1 x 100 mL) and dried over MgSO4. After removal of solvent under reduced pressure, the residue was further purified by column chromatography (cyclohexane : ethyl acetate = 1 : 1, Rf = 0.4). The title product was obtained as colourless oil (718 mg, 89%). 
Compound 11
Compound 9 (236 mg, 0.29 mmol, 1 eq.) and 10 (1.2 eq., 0.35 mmol, 130 mg) were dissolved in dry DMF under argon atmosphere. Copper(I) iodine (0.15 eq., 0.0435 mmol, 8 mg) was added to above solution. After stirring at 60 °C for 18 h, the mixture was quenched by 10% HCl (100 mL) and extracted with DCM (150 mL). The organic phase was further washed with 10% HCl (1 x 100 mL), water (1 x 100 mL), and brine (1 x 100 mL) and dried over MgSO4. After removal of solvent under reduced pressure, the residue was further purified by column chromatography (DCM : methanol = 95 : 5, Rf = 0.47). The title product was obtained as colourless oil (300 mg, 87%). 
Compound 12 -Ad2Man1
To a solution of 11 (105 mg, 0.089 mmol, 1 eq.) in dry methanol (5 mL) under argon atmosphere, sodium methoxide (1.5 eq., 0.133 mmol, 7 mg) was added. After stirring for 6 h at room temperature, the mixture was diluted with methanol (p.a.) and neutralised by Dowex ion exchange resin. The title product was obtained after filtration and concentration under reduced pressure as colourless oil (48 mg, 53%). 
Compound 13
To a solution of TRIS (2.42 g, 20 mmol, 1eq.) in DMSO (5 mL), 5 M of NaOH aqueous solution (2 mmol, V = 0.4 mL) was added. tert-butyl acrylate (3.5 eq., 70 mmol, V = 10 mL) was added before the mixture was stirring at room temperature overnight. After removal of solvent under reduced pressure, the residue was further purified by column chromatography (ethyl acetate : cyclohexane = 2 : 1 + 0.05 v/v% methanol, Rf = 0.3). The title product was obtained as colourless oil (2.97 g, 29%). 
Compound 14
Compound 8 (123 mg, 0.16 mmol, 1.1 eq.) and compound 13 (73 mg, 0.144 mmol, 1 eq.) were dissolved in dry THF (5 mL) under argon atmosphere. PyBOP (1 eq., 0.16 mmol, 83 mg) and DIPEA (4 eq., 0.64 mmol, V = 0.11 mL) were added. After stirring at room temperature for 18 h, the mixture was quenched by 10% HCl (100 mL) and extracted with DCM (150 mL). The organic phase was washed with 10% HCl (1 x 100 mL), NaHCO3 (1 x 100 mL), and brine (1 x 100 mL) and dried over MgSO4. After removal of solvent, the residue was further purified by column chromatography (ethyl acetate : methanol = 90 : 5, Rf = 0.75). The title product was obtained as colourless oil (170 mg, 84%). 
Compound 15
To a solution of 14 (170 mg, 0.135 mmol, 1 eq.) in dry methanol (10 mL) under argon atmosphere, acetyl chloride (10 eq., V = 0.1 mL) was added dropwise. After stirring for 18 h, the mixture was quenched by 10% HCl (50 mL) and extracted with DCM (50 mL). The organic phase was washed with 10% HCl (1 x 50 mL) and brine (1 x 50 mL) and dried over MgSO4. The title product was obtained after removal of solvent under reduced pressure (130 mg, 85%). 
Compound 16
To a solution of 15 (130 mg, 0.115 mmol, 1 eq.) in methanol (10 mL), the same volume of lithium hydroxide (13 eq., 1.5 mmol, 36 mg) aqueous solution was added. After stirring at room temperature for 18 h, the mixture was quenched by 10% HCl (50 mL) and extracted with DCM (50 mL). The organic phase was washed with 10% HCl (1 x 50 mL) and brine (1 x 50 mL) and dried over MgSO4. The title product was obtained after removal of solvent under reduced pressure (92 mg, 73%). 
Compound 17
To a solution of 16 (213 mg, 0.19 mmol, 1 eq.) in dry THF (15 mL) under argon atmosphere, PyBOP (3.5 eq., 0.68 mmol, 354 mg) was added. After propargyl amine (3.5 eq., 0.68 mmol, V = 0.043 mL) and DIPEA (12 eq., 2.28 mmol, V = 0.4 mL) were added, the mixture was stirred at room temperature overnight. The mixture was quenched by 10% HCl (100 mL) and extracted with DCM (100 mL). The organic phase was washed with 10% HCl (1 x 100 mL), saturated NaHCO3 (1 x 100 mL), and brine (1 x 100 mL) and dried over MgSO4. After removal of solvent under reduced pressure, the residue was further purified by column chromatography (DCM : methanol = 95 : 5, Rf = 0.3). The title product was obtained as colourless oil (165 mg, 72%). 
Compound 18
Compound 10 (206 mg, 0.55 mmol, 3.6 eq.) and 17 (185 mg, 0.154 mmol, 1 eq.) were dissolved in dry DMF (15 mL) under argon atmosphere. Copper (I) iodine (0.5 eq., 0.077 mmol, 15 mg) was added and the mixture was stirred at 70 °C overnight. After removal of DMF, the residue was extracted with DCM (100 mL) and 10% HCl (100 mL). The organic phase was washed with water (1 x 100 mL) and brine (1 x 100 mL) and dried over MgSO4. After removal of solvent under reduced pressure, the residue was further purified by column chromatography (DCM : methanol = 90 :10, Rf = 0.25). The title product was obtained as colourless oil (244 mg, 68%). 
Compound 19 -Ad2Man3
To a solution of 18 (74 mg, 0.032 mmol, 1 eq.) in dry methanol (5 mL) under argon atmosphere, sodium methoxide (1.5 eq, 0.048 mmol, 3 mg) was added. After stirring at room temperature for 6 h, the mixture was diluted with methanol (p. a.) and neutralised by Dowex ion exchange resin. The title product was obtained after filtration and concentration under reduced pressure as colourless solid (50 mg, 53%). 
Compound 20
To a solution of 2 (0.858 g, 1.78 mmol, 1 eq.) in DMF, sodium azide (5 eq., 8.9 mmol, 0.58 g) was added in one portion. The reaction mixture was stirred at 80 °C for overnight before evaporation of solvent. The residue was dissolved in 100 mL DCM and extracted with water (1 x 100 mL) and brine (2 x 100 mL). The organic phase was collected and dried over MgSO4 before removal of solvent under reduced pressure. The product was obtained as colourless oil (537 mg, 85%).
Molecular formula: C18H31N3O4
To a solution of protected dendron [G1-OH] (5 g, 15.61 mmol) in THF, sodium hydride (1.123 g, 46.82 mmol) was added and stirred at 50 °C for 1 h. Propargyl bromide (4.43 mL, 46.82 mmol) was added slowly to the reaction mixture and stirred at room temperature overnight. The progress of the reaction was analysed by TLC; the excess of NaH was quenched by the dropwise addition of water while keeping the reaction flask in an ice bath. The reaction mixture was concentrated under reduced pressure and diluted with water. The compound was extracted with DCM and the organic layer was combined and dried over MgSO4. The reaction mixture was concentrated and purified by column chromatography to obtain a pale yellow oily product. (yield: 4.25 g, 76%). 
Compound 23
To a mixture of 20 (1 g, 2.82 mmol) and 21 (2 g, 5.65 mmol) in DMF, copper sulphate solution (0.022 g, 0.14 mmol, aq. 0.1 M) and sodium ascorbate (0.11 g, 0.56 mmol, 0.2 M) were added. The reaction mixture was stirred at room temperature overnight. After complete consumption of the azide, checked by IR spectroscopy, the stirring was stopped and solvent was removed under reduced pressure and diluted with water. Organic compound was extracted from the aqueous phase using DCM. The combined organic phase was washed with saturated EDTA solution and water and dried over Na2SO4. The reaction mixture was concentrated and purified by column chromatography on silica gel (n-hexane/ethyl acetate, 3:2) to obtain the pale yellow oily product (1.42 g, yield: 80%). 
Compound 24 -Ad1OH4
23 (1 g, 1.40 mmol) was dissolved in 1% aq. TFA (10 ml) and stirred at room temperature overnight. Deprotection reaction was monitored by using NMR. After complete deprotection, the solvent was removed and the compound was dissolved in water and dialyzed. Freeze-drying yielded a colourless solid (yield: 0.66 g, 76%).
Molecular formula: C30H53N3O11

Compound 25 -Ad1Su4
After drying for 18 h under high vacuum at 60 °C, 24 (0.5 g, 0.79 mmol) was dissolved in dry DMF under inert conditions. The solution was heated to 60 °C and sulphur trioxide pyridine complex (2.5 g, 15.8 mmol), dissolved in a minimum amount of dry DMF, was added dropwise. The reaction mixture was stirred for 18 h at 60 °C and further for 48 h at room temperature. Then, the reaction was quenched by adding 10 mL deionized water. To the aqueous solution, 1 M NaOH was added immediately until pH 11 was reached. Solvent was removed under vacuum and was further purified by dialysis (MWCO = 500-1000 Da) in saturated aqueous NaCl solution and water. After dialysis the product was obtained by freeze-drying as colourless solid (yield: 0.52 g, 64%). 
Compound 26
Similar procedure as for 23: 20 (0.5 g, 1.41 mmol) and 22 (2.0 g, 2.82 mmol) were coupled using copper sulphate (0.01 g, 0.07 mmol) and sodium ascorbate (0.05 g, 0.28 mmol) assisted click reaction (yield: 1.19 g, 78%). 
Compound 27 -Ad1OH8
The deprotection was performed by similar procedure as described for 24 (yield: 0.57 g, 68%). 
Compound 28 -Ad1Su8
The sulphation was accomplished by using a similar procedure as for 25 using 28 (0.50 g, 0.53 mmol).
(yield: 0.55 g, 60%). 
Compound 29
To a solution of 8 (0.5 g, 0.65 mmol, 1eq.) in dry DMF under argon atmosphere, EDC hydrochloride (1.5 eq., 0.975 mmol, 187 mg) and 1-hydroxybenzotriazole hydrate (1.5 eq., 0.975 mmol, 132 mg) were added. After stirring for 30 minutes, N-methylmorpholine (1.5 eq., 0.975 mmol, V = 1.1 mL) and 2-azidoethan-1-amine (1.5 eq., 0.975 mmol, 84 mg) were added and stirred at room temperature overnight. The reaction mixture was quenched by saturated NaHCO3 solution (100 mL) and extracted with DCM (100 mL). The organic phase was further washed with 10 % HCl (1 x 100 mL), water (1 x 100 mL), and brine (1 x 100 mL) and dried over MgSO4. After removal of solvent under reduced pressure, the residue was further purified by column chromatography (ethyl acetate, Rf = 0.25). The title product was obtained as colourless oil (400 mg, 73%). 
Compound 30
A similar procedure as for 23 was followed for the coupling of 29 (0.50 g, 0.59 mmol) and 22 (1.29 g, 1.77 mmol) using copper sulphate (0.004 g, 0.02 mmol) and sodium ascorbate (0.02 g, 0.11 mmol) assisted click reaction (yield: 0.69 g, 75%). 
Compound 31
The deprotection was performed by similar procedure as 24 (yield: 0.40 g, 70%). 
Compound 32 (Ad2Su8)
The sulphation was done by using a similar procedure as for 25 (yield: 60%). 2c. Synthesis route of Ad2Man8 Figure S4 . Synthesis routes of octa-mannoside ligand Ad2Man8.
Compound 33
Diadamantane-carboxylic acid 8 (400 mg, 0.52 mmol) and G2-Amine 1 (539 mg, 0.77 mmol) were dissolved in dry THF (10mL) under argon atmosphere. After cooling to 0°C, EDC•HCl (148 mg, 0.77 mmol) and catalytic amounts of DMAP were added to the reaction mixture, which was kept stirring overnight while warming to room temperature. Afterwards, the solvent was removed under reduced pressure. The residue was dissolved in DCM and washed with NaHCO3 solution, brine and water. The organic layer was dried over Na2SO4 before being concentrated in vacuo. The crude product was purified by column chromatography (Silica, DCM/MeOH (0-4%)), which yielded the desired product as yellow oil (523 mg, 69%). 
Compound 34
Acetal-protected diadamantane-G2 33 (490 mg, 0.34 mmol) was dissolved in 10 mL methanol. After addition of Dowex-H (2 eq, by weight), the reaction mixture was kept stirring until complete conversion was reached. The reaction was monitored by TLC and NMR. After completion, Dowex-H was filtered off and washed with methanol. The filtrate was concentrated in vacuo yielding the title compound as slight yellow oil (415 mg, 95%). 
OD400 agglutination assay for surface coverage dependent measurements
Binding properties of mannoside-functionalised vesicles were further analysed with respect to the dependence between the vesicle's surface coverage with ligands and their ability to form agglomerates.
The agglutination of vesicles, which was mediated by binding to ConA, was observed by optical density measurements at a fixed wavelength of λ = 400 nm (OD400). Concentrations of vesicles and mannoside ligands were chosen so that, in general, every cyclodextrin formed an inclusion complex with an adamantyl residue. This concentration relation is referred to as 100% surface coverage.
In a first experiment, the agglutination of the vesicles with different ligands was tested ( Figure S8b ).
Here, all vesicles exhibited a surface coverage of 100%. All tested ligand-vesicles complexes showed high capabilities to provoke agglutination, as can be seen by the increasing optical absorption with time.
Additionally, Ad2-Man1 not only showed agglutination but also an additional cross-linking of CDVs even in absence of ConA (area between green and red arrow in Figure S8c . This behaviour was observed and described before by Kauscher et al. 3 and can be understood from the ability of the two adamantyl residues to bind to two different vesicles, hence, inducing intervesicular crosslinking. For larger mannoside complexes (Ad2Man3 and Ad2Man8), the self-aggregation from CDVs was no longer observed due to the highly branched and sterically demanding mannoside structures.
In order to investigate the dependence between CDV's surface coverage and their aggregation behaviour, a second set of experiments with changing carbohydrate concentrations on the CDVs was performed. A lower concentration of ligands on the vesicle's surface was achieved by replacing the mannosides with inactive adamantyl tetraethyleneglycol (Ad-TEG-OH). The ratio between active and inactive ligands was varied between 10% and 100%, in order to receive the desired surface coverage.
Ligand-concentration dependent aggregation was observed in all cases (Figures S9). Figure S8c compares the measured absorbance at a fixed time (t = 40 min) for different surface coverage and different ligands. A bisected behaviour with two distinct regions was observed, which are indicated by grey lines as guide to the eye in Figure S8c . For surface coverage below 20%, the gain in absorbance is rather steep for all ligands. With further surface coverage, the curve flattens drastically and no substantial increase of aggregation is observed. Hence, a threshold of around 20% surface coverage for effective aggregation can be deduced from the measured data. Furthermore, no significant difference was observed for the three ligands tested. This behaviour can be explained by considering the assay setup, i.e., to initiate aggregation, two functionalised CDVs need to bind through their ligands to one of the four binding sites of the same ConA. Here, the valency of the ligand plays an inferior role, as a simple monovalent binding in both cases already leads to aggregation. By considering the dimensions of the CDVs compared to ConA, it appears to be obvious that an increased ligand concentration after a certain threshold does not affect the aggregation substantially due to steric reasons. At the utmost, the strength and stability of the aggregate might be increased due to additional crosslinking. The selectivity of our supramolecular scaffold was confirmed by additional OD400 experiments. A similar setup as before was applied, while the lectin PNA instead of Con A was added to the guest functionalised CDV solutions. Peanut agglutinin (PNA) is a plant lectin protein and binds to galactose. As can be seen in 
5b. Addition of γ-CD
γ-CD was able to prevent binding of adamantyl moieties to the dextran layer, however, reversible binding to the CDVs was still favoured due to the much higher binding affinity of adamantane to β-CD.
According to reported literature, the affinity between adamantane and γ-CD (Ka = ~10 2 M -1 ) was two orders lower than for β-CD (Ka = ~10 4 M -1 ). 4 In order to prove that the addition of γ-CD did not affect our supramolecular system, control experiments were performed. Shape and size consistency of the vesicles after the addition of γ-CD was confirmed by DLS and Cryo-TEM experiments. Determined hydrodynamic diameters were found to remain unchanged, which indicates morphological stability upon addition of γ-CD (Fig. S12a) . The corresponding micrographs obtained from cryo-TEM experiments showed likewise mono-and multilayer vesicles with intact membranes. Secondly, the influence of addition γ-CD on agglutination of ligand-decorated CDV in the presence of ConA was studied by OD400 measurements ( Figure S12b ). Ad2Man3 and Ad2Man8 were applied as test ligands. It can be seen that the effect of additional γ-CD is of minor influence since all of the measurements show a similar absorbance and aggregation rate. These experiments supported our claims that our SPR setup gave us reliable results. 
